TDCS + Phonomotor Therapy for Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to assist people with aphasia, a condition that often impairs speaking and understanding language after a stroke. It combines Phono-Motor Treatment (PMT), a language therapy, with transcranial direct current stimulation (tDCS), a gentle brain stimulation that may enhance learning. The trial aims to determine if adding tDCS to PMT improves reading skills more effectively than PMT alone. Individuals who had a stroke over six months ago, have been diagnosed with aphasia, and struggle with reading aloud may be suitable for this study. As an unphased study, this trial provides a unique opportunity to explore innovative treatments for aphasia.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this approach is safe for individuals with aphasia?
Research has shown that transcranial direct current stimulation (tDCS) is generally safe for stroke patients with language difficulties. In a review of studies, only 11.62% reported any side effects, most of which were mild, such as itching (70%) and a burning sensation. Another study confirmed that this brain stimulation method is noninvasive, safe, and painless. It uses a small electrical current that may enhance language skills when combined with speech therapy. Overall, tDCS appears promising, with few side effects reported.12345
Why are researchers excited about this trial?
Researchers are excited about using Transcranial Direct Current Stimulation (tDCS) combined with Phonomotor Therapy (PMT) for aphasia because it offers a non-invasive approach to enhance brain function. Unlike traditional speech and language therapies that focus solely on exercises, tDCS uses a mild electrical current to stimulate specific brain areas, potentially speeding up recovery. The trial explores different combinations: Early tDCS starts with active stimulation, Late tDCS introduces it after initial sham sessions, and Interleaved tDCS alternates active and sham sessions. This variety seeks to determine the most effective timing and combination, aiming for faster and more significant improvements in communication skills.
What evidence suggests that this trial's treatments could be effective for aphasia?
Research has shown that a gentle electrical brain stimulation technique called transcranial direct current stimulation (tDCS), when combined with language therapy, can help people with aphasia improve their language skills. In this trial, participants will join different groups to receive various combinations of tDCS and phonomotor therapy (PMT). Studies suggest that tDCS can enhance speech and communication, especially when paired with speech and language therapy. Evidence indicates that tDCS helps people with long-term aphasia name things more effectively than therapy alone. This suggests that adding tDCS to regular language therapy might lead to better reading and language recovery for those who have aphasia due to a stroke.15678
Are You a Good Fit for This Trial?
This trial is for individuals who have aphasia, a language disorder often caused by stroke. Participants should struggle with reading due to their condition and are looking to improve their abilities through therapy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive different combinations of PMT and tDCS over six weeks, with assessments before, during, and after treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Transcranial Direct Current Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kessler Foundation
Lead Sponsor
Medical College of Wisconsin
Collaborator